Catherine Fiévet

8.8k total citations · 1 hit paper
117 papers, 7.4k citations indexed

About

Catherine Fiévet is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Catherine Fiévet has authored 117 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 54 papers in Molecular Biology and 34 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Catherine Fiévet's work include Cholesterol and Lipid Metabolism (36 papers), Peroxisome Proliferator-Activated Receptors (36 papers) and Lipoproteins and Cardiovascular Health (32 papers). Catherine Fiévet is often cited by papers focused on Cholesterol and Lipid Metabolism (36 papers), Peroxisome Proliferator-Activated Receptors (36 papers) and Lipoproteins and Cardiovascular Health (32 papers). Catherine Fiévet collaborates with scholars based in France, United States and Sweden. Catherine Fiévet's co-authors include Bart Staels, Jean‐Charles Fruchart, Anne Tailleux, Johan Auwerx, Nathalie Hennuyer, Megan C. Holmes, Nicholas M. Morton, John J. Mullins, Jonathan R. Seckl and Hélène Duez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Catherine Fiévet

116 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protective Role of Interleukin-10 in Atherosclerosis

1999 647 citations Hélène Duez, Catherine Fiévet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Fiévet France	46	3.3k	2.7k	2.3k	1.3k	1.1k	117	7.4k
Takanari Gotoda Japan	48	3.8k 1.1×	3.1k 1.2×	1.8k 0.8×	1.3k 1.0×	1.4k 1.3×	114	8.4k
Jun-ichi Osuga Japan	42	3.7k 1.1×	3.1k 1.2×	1.3k 0.6×	1.7k 1.3×	1.6k 1.4×	85	7.8k
Ken Ohashi Japan	37	3.2k 1.0×	2.5k 0.9×	1.0k 0.5×	1.1k 0.8×	1.3k 1.2×	85	6.4k
Colin H. Macphee United States	41	2.6k 0.8×	2.5k 0.9×	944 0.4×	970 0.8×	1.7k 1.6×	90	7.1k
Lawrence W. Castellani United States	41	2.2k 0.7×	1.8k 0.7×	1.3k 0.6×	766 0.6×	852 0.8×	71	6.6k
Thomas W. Doebber United States	34	6.0k 1.8×	2.1k 0.8×	1.9k 0.8×	2.4k 1.9×	1.6k 1.5×	58	9.1k
Sotirios K. Karathanasis United States	42	3.1k 0.9×	2.1k 0.8×	1.5k 0.6×	831 0.6×	639 0.6×	85	6.2k
Anne Tailleux France	40	2.4k 0.7×	1.7k 0.6×	1.4k 0.6×	1.2k 1.0×	1.9k 1.7×	100	6.0k
Renee Leboeuf United States	49	2.4k 0.7×	1.7k 0.6×	1.0k 0.5×	1.3k 1.0×	1.1k 0.9×	107	6.5k
Inès Pineda‐Torra United Kingdom	38	4.5k 1.4×	2.0k 0.7×	743 0.3×	1.4k 1.1×	1.4k 1.3×	76	7.7k

Countries citing papers authored by Catherine Fiévet

Since Specialization

Citations

This map shows the geographic impact of Catherine Fiévet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Fiévet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Fiévet more than expected).

Fields of papers citing papers by Catherine Fiévet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Fiévet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Fiévet. The network helps show where Catherine Fiévet may publish in the future.

Co-authorship network of co-authors of Catherine Fiévet

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Fiévet. A scholar is included among the top collaborators of Catherine Fiévet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Fiévet. Catherine Fiévet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Režen, Tadeja, Peter Juvan, Damjana Rozman, et al.. (2011). Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle. BMC Genomics. 12(1). 96–96. 15 indexed citations

2.

Abdelkarim, Mouaadh, Sandrine Caron, Christian Duhem, et al.. (2010). The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin Pathways. Journal of Biological Chemistry. 285(47). 36759–36767. 76 indexed citations

3.

Tancevski, Ivan, Egon Demetz, Kathrin Eller, et al.. (2010). The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice. PLoS ONE. 5(1). e8722–e8722. 43 indexed citations

4.

Calpe‐Berdiel, Laura, et al.. (2008). Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. Journal of Lipid Research. 49(9). 1904–1911. 74 indexed citations

5.

Rotllán, Noemí, et al.. (2008). LIVER X RECEPTOR-MEDIATED ACTIVATION OF MACROPHAGE-SPECIFIC REVERSE CHOLESTEROL TRANSPORT IN VIVO REQUIRES ATP-BINDING CASSETTE (ABC) G5/G8. Atherosclerosis Supplements. 9(1). 43–43. 2 indexed citations

6.

MacDonald, Marcia L.E., Roshni R. Singaraja, Nagat Bissada, et al.. (2007). Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. Journal of Lipid Research. 49(1). 217–229. 53 indexed citations

7.

Louche, Katie, Bruno Lefebvre, Antoine Pilon, et al.. (2007). S 26948. Diabetes. 56(11). 2797–2808. 42 indexed citations

8.

Tancevski, Ivan, Andreas Wehinger, Egon Demetz, et al.. (2006). Hyperthyroidism decreases plasma HDL cholesterol by inhibition of hepatic ABCA1 expression. Data Archiving and Networked Services (DANS). 1 indexed citations

9.

Singaraja, Roshni R., Miranda Van Eck, Nagat Bissada, et al.. (2006). Both Hepatic and Extrahepatic ABCA1 Have Discrete and Essential Functions in the Maintenance of Plasma High-Density Lipoprotein Cholesterol Levels In Vivo. Circulation. 114(12). 1301–1309. 66 indexed citations

10.

Morton, Nicholas M., J. Paterson, Hiroaki Masuzaki, et al.. (2003). Reduced intra-adipose glucocorticoid regeneration: A novel adaptive response to, and therapy for, the metabolic syndrome. 2 indexed citations

11.

Meir, Karen, Daniel Kitsberg, Irit Alkalay, et al.. (2002). Human Sterol 27-Hydroxylase (CYP27) Overexpressor Transgenic Mouse Model. Journal of Biological Chemistry. 277(37). 34036–34041. 63 indexed citations

12.

Singaraja, Roshni R., Catherine Fiévet, Graciela Castro, et al.. (2002). Increased ABCA1 activity protects against atherosclerosis. Journal of Clinical Investigation. 110(1). 35–42. 15 indexed citations

13.

Singaraja, Roshni R., Catherine Fiévet, Graciela Castro, et al.. (2002). Increased ABCA1 activity protects against atherosclerosis. Journal of Clinical Investigation. 110(1). 35–42. 206 indexed citations

14.

Raspé, Eric, Hélène Duez, Philippe Gervois, et al.. (1999). Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor Rev-erba.. Circulation. 1 indexed citations

15.

Staels, Bart, Nicolas Duverger, Anne Tailleux, et al.. (1995). Tissue-specific Expression of the Human Gene for Lecithin: Cholesterol Acyltransferase in Transgenic Mice Alters Blood Lipids, Lipoproteins and Lipases towards a Less Atherogenic Profile. European Journal of Biochemistry. 230(2). 567–575. 49 indexed citations

16.

Tailleux, Anne, et al.. (1993). Modulation of the expression of human LDL-Apo B-100 epitopes by lipids and apolipoproteins.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(4). 529–535. 7 indexed citations

17.

Fiévet, Catherine & J C Fruchart. (1991). HDL heterogeneity and coronary heart disease. Diabetes/Metabolism Reviews. 7(3). 155–162. 17 indexed citations

18.

Reade, Richard, C Cachera, Patrick Duriez, et al.. (1989). Apolipoprotein B Immunochemical Heterogeneity in Dialysed Patients with Chronic Renal Failure and Patients with Coronary Artery Stenosis. American Journal of Nephrology. 9(2). 110–114. 4 indexed citations

19.

Fiévet, Catherine, J C Fruchart, S. E. Salmon, et al.. (1987). Electroimmunoassay for determination of ApoB in human sera by using a mixture of monoclonal antibodies.. Clinical Chemistry. 33(6). 1070–1070. 6 indexed citations

20.

Delpierre, Cyrille, César B. Gutiérrez‐Martín, J. C. Gesquière, et al.. (1987). Chemical approach to synthetic immunogens in clinical chemistry. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 14(4). 281–288. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact